August 2006

New Director of Research at the ALS Society of Canada

Denise Figlewicz, PhD, will join the ALS Society of Canada on September 5, 2006 as Director of Research. The position of Director of Research is a newly created position for ALS Canada. Dr. Figlewicz’s research career has focused on mammalian nervous system development and pathology, specifically molecular genetic and cell approaches to investigate neuromuscular diseases such as ALS. She has been involved in the ALS research field since the 1980s.

Couple wanted on stem-cell therapy fraud charges

A Cape Town couple were accused of exploiting desperate patients by providing them with ampoules containing cord stem-cells from a registered laboratory. The couples clients were from across the world and suffered from neurological degenerative diseases such as multiple sclerosis, amyotrophic lateral sclerosis and cerebral palsy.

Charity Benefit Country BBQ and Auction

Saturday, September 16th, 2006 at 4:00pm in Nokesville, Virginia that ALS Association will be having a charity benefit, BBQ and silent auction in support of ALS Research.

American Biogen buys into Canadian Amorfix Life

Toronto-based Amorfix Life is joining the American-based Biogen of Cambridge, Massacheusettes and includes options to license the worldwide rights to Amorfix's technology. Amorfix develops and commercializes therapeutic treatments for Lou Gehrig's Disease (Amyotrophic Lateral Sclerosis).